Goserelin Implant 10.8 mg and Lorcaserin Extended-Release Tablets
Determining the interaction of Goserelin Implant 10.8 mg and Lorcaserin Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: goserelin
Brand name: Zoladex
Synonyms: Goserelin (implant), Goserelin
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Goserelin Implant 10.8 mg-Lorcaserin Hydrochloride
- Goserelin Implant 10.8 mg-Lorcaserin Tablets
- Goserelin Implant 10.8 mg-Lorcet
- Goserelin Implant 10.8 mg-Lorcet Plus
- Goserelin Implant 10.8 mg-Lorcet Tablets
- Goserelin Implant 10.8 mg-Lorlatinib
- Lorcaserin Extended-Release Tablets-Goserelin Implant 3.6 mg
- Lorcaserin Extended-Release Tablets-Goserelin Subcutaneous
- Lorcaserin Extended-Release Tablets-Grafco Applicator
- Lorcaserin Extended-Release Tablets-Grafco Silver Nitrate
- Lorcaserin Extended-Release Tablets-Gralise
- Lorcaserin Extended-Release Tablets-Granisetron